The expression of REV1 in multiple tumour and normal tissue types from the Oncomine database revealed that expression of this gene was elevated relative to normal tissue controls for brain, renal, prostate cancers, melanoma, myeloma and sarcoma. Here, REV1 is linked to neoplasm.